Day One, Tuesday, April 16th - ET (Eastern Time, GMT-05:00)
Day One, Tuesday, April 16th - ET (Eastern Time, GMT-05:00)
- John Oroho - President and General Manager, RLDatix Life Sciences
- Keren Bisnauth, JD - Associate Vice President of Legal & Regulatory, RLDatix Life Sciences
- Audrey DeGuarde - Vice President of Customer Success and Compliance Operations, RLDatix Life Sciences
- Masha Goodman-Khan - Senior Director of Compliance & Legal Operations, Vericel Corporation
- Elizabeth Weiss - Head of Compliance, Americas & EMEA, Lupin Inc.
- Seth Lundy - Partner, King & Spaulding
- Rod Rosenstein - Partner, King & Spalding LLP
- Kendrick Meek - Senior Advisor, King & Spalding LLP
- Ander Crenshaw - Crenshaw, King & Spalding LLP
- James Stansel - Executive Vice President, General Counsel and Corporate Secretary, PhRMA
- Craig Bleifer - Partner, Akin Gump Strauss Hauer & Feld LLP
- Jacqueline Romero - United States Attorney, United States Attorney’s Office for the Eastern District of Pennsylvania
- Jason Gould - Chief, Health Care Fraud Unit, United States Attorney's Office, District of New Jersey
- Kelly Lawrence - Chief of Health Care Fraud Unit, United States Attorney’s Office, District of Massachusetts
- Bio/Pharma Compliance Basics and Frameworks
- Key Learnings from Industry’s Most Recent CIAs and Enforcement Activity
*Participants in this session will be partnered with a senior leader post event as part of Informa Connect’s Compliance and Legal Mentorship Program.
- Scott Liebman - Partner and Chair, FDA Regulatory & Compliance; Co-Chair, Life Sciences, Sheppard Mullin Richter & Hampton LLP
- Dominick DiSabatino - Partner, Sheppard Mullin Richter & Hampton LLP
- Enhancing Compliance Programs Based on 2023 OIG and DOJ Guidance
- New and Emerging Risk Areas for 2024 and Beyond
- Natasha Trifun - Executive Director, Head of Compliance, R&D, Global Medical, External Funding & Global Functions, Alexion, AstraZeneca Rare Disease
- Robert Melillo - Managing Director, G&M Health, LLC
- Rore Middleton - Vice President, Compliance & Ethics, Blueprint Medicines
- Stefanie Doebler - Partner, Covington and Burling LLP
- Collaborating with the Board to Advance the Needs of the Compliance Teams
- Staffing, Resource Planning, Career Progression
* Informa Connect reserves the right to qualify participants for this Summit. Attendees must be a CCO, VP or GC, or Senior Director and currently employed by a life sciences manufacturer.
- Ann Beasley - Senior Vice President and Chief Compliance Officer, Zai Lab
- Melissa Lozner - Senior Vice President, Chief Compliance Officer, Regeneron
- David Berger - Senior Managing Director, Ankura
- Samantha Sutherland - Director, Baker Tilly
- Casey Armstrong - Experienced Manager, Baker Tilly
- Jennifer Sanfilippo - General Counsel and Chief Compliance Officer, Melinta Therapeutics
- Genevieve Spires - Senior Legal Counsel, Melinta Therapeutics
- Donna White - Vice President, Compliance Officer, Chiesi USA Inc.
- Michael Hercz - Senior Vice President & General Counsel, Sentynl Therapeutics Inc.
- Samantha Barrett Badlam - Partner, Ropes & Gray LLP
- Fabien Saint-Gerard - Vice President, Head Internal Audit R&D and Strategy & Growth, Novartis
- Michael Shaw - Principal, Global Head of Risk & Compliance, ZS Associates
When we think about the “digital frontier” our thoughts immediately go to AI, and understandably so. It seems like there are new advances in AI every day, with the promise of making the lives of compliance professionals easier. However, when it comes to compliance training, we’re constrained by the toolset for developing training and the technology platforms for delivering the training, which are lagging behind broader technological trends.
But there is a broader challenge at play. Coupled with the need to train “digital natives,” employees who have grown up on the so-called digital frontier, these limiting platforms present compliance leaders with a conundrum: how to use what we’ve got to effectively train digital natives as well as the “digital immigrants” within our organizations. This session aims to provide practical ideas for addressing this conundrum while leveraging the power of new technologies and embracing new ways to use tried and true approaches.
- Daniel O’Connor - Senior Vice President, NXLevel Compliance
- Cristina List - Director, Compliance Advisory Services, MedPro Systems
- Makaylah Johnson - Manager, Compliance Advisory Services, MedPro Systems
- Tracy Palmer Berns - SVP, Chief Compliance & Quality Assurance Officer, Ionis Pharmaceuticals
- Noah Goldstein - Counsel, Life Sciences Regulatory and Compliance, Porzio Bromberg & Newman, P.C.
- Michelle Axelrod - Principal, Life Sciences Regulatory and Compliance, Porzio, Bromberg & Newman, P.C.
- Kari Loeser - Vice President & Chief Compliance Officer, Cytokinetics
- Kris Hall, JD, CIPP/CIPM - Managing Director, Dovetail Consulting Group